Posts Tagged ‘acute’
Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal
Medical device company Vertos Medical Inc. has reported that an observational study on mild*, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).1 The study, conducted by leading pain physicians Timothy Deer, M.D…
FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL. This is the only FDA approved morphine sulfate oral solution available at this concentration…
SUMAVEL(TM) DosePro(TM) Available In The United States To Treat Acute Migraine And Cluster Headaches
Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical company, and Astellas Pharma U.S., Inc. (“Astellas”) announced the U.S. commercial launch of SUMAVEL? DosePro? (sumatriptan injection) needle-free delivery system. In July 2009, the U.S…
QRxPharma Initiates Pivotal Phase 3 Study Of MoxDuo(TM)IR For Moderate To Severe Acute Pain
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced, as part of its Phase 3 program, the initiation of a registration (also called pivotal) trial (Study 008) comparing efficacy and safety profiles of MoxDuo(TM)IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery…
New Data Presented At ACR Meeting Demonstrates Colcrys(TM) (Colchicine, USP) Significantly Reduces Pain Of Acute Gout Flare Within 24 Hours
URL Pharma, Inc., announced data from a pivotal Phase III study demonstrating that Colcrys(TM) (colchicine, USP), a low-dose colchicine, reduced the pain of gout flares within a 24-hour period as effectively as high-dose colchicine with a side effect profile statistically indistinguishable from placebo. These data and two other Colcrys studies were presented this week at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting in Philadelphia.
CT Scans Show Patients With Severe Cases Of H1N1 Are At Risk For Developing Acute Pulmonary Emboli
Researchers utilizing computed tomography (CT) scans have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli (PE), according to a study to be published online Oct. 14, 2009, in the American Journal of Roentgenology. The study will be published in the December issue of the AJR. A pulmonary embolism occurs when one or more arteries in the lungs become blocked.
What Is Irritable Hip? What Is Acute Transient Synovitis? What Causes Irritable Hip?
The most common cause of hip pain in young children is the inflammation or swelling of the membrane covering the hip joint. It is known as irritable hip or acute transient synovitis. According the Medilexicon’s medical dictionary, synovitis is: “Inflammation of a synovial membrane, especially that of a joint; in general, when unqualified, the same as arthritis.
Primary Care Physicians Are Front Line Defense In Diagnosing Serious Illness In Patients With Acute Lower Back Pain
A study by researchers at The George Institute for International Health in Australia found that it is rare for patients presenting to PCPs with acute lower back pain to have previously undiagnosed serious diseases. The most common serious disease cause documented was vertebral fracture, with half of the cases identified at the time of initial consultation.
For Patients With Acute Lower Back Pain, PCPs Are Front Line Defense In Diagnosing Serious Illness
A study by researchers at The George Institute for International Health in Australia found that it is rare for patients presenting to PCPs with acute lower back pain to have previously undiagnosed serious diseases. The most common serious disease cause documented was vertebral fracture, with half of the cases identified at the time of initial consultation.
China Aoxing Pharmaceutical Company Announces Submission Of NDA Of Its Leading Narcotic Drug For The Treatment Of Acute Moderate To Severe Cough
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) (“China Aoxing”), a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has submitted a new drug application (NDA) to the China State Food and Drug Administration (SFDA) for its Codeine Phosphate, a compound oral solution for the treatment of acute moderate to severe cough.
Rx Drug Compare
Translator
By N2H